Multicenter randomized double masked parallel design exploratory study to assess safety and efficacy of two different doses of intravitreal anti-VEGF treatment with ranibizumab (0.06 mg vs. 0.18 mg) in infants with retinopathy of prematurity (ROP)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: since 01/02/2015
Description
Keywords: Klinische Studie
Funding identifier: EudraCT No. 2013-002539-13
Funder / funding scheme:
- Other public funder
Project management at the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |
Applicants from the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |